The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 17 , ISSUE 6 ( June, 2016 ) > List of Articles


Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review

Akshit Batra, Sujata Yerawadekar

Citation Information : Batra A, Yerawadekar S. Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review. J Contemp Dent Pract 2016; 17 (6):504-510.

DOI: 10.5005/jp-journals-10024-1880

Published Online: 01-11-2016

Copyright Statement:  Copyright © 2016; The Author(s).


How to cite this article

Sarode GS, Batra A, Sarode SC, Yerawadekar S, Patil S. Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review. J Contemp Dent Pract 2016;17(6):504-510.

PDF Share
  1. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008 Sep;25(9):2097-2116.
  2. Pathogenesis of hereditary tumors: beyond the “two-hit” hypothesis. Clin Genet 2002 Nov;62(5):345-357.
  3. Mechanisms of inherited cancer susceptibility. J Zhejiang Univ Sci B 2008 Jan;9(1):1-4.
  4. A new theory on cancer-inducing mechanism. Br J Cancer 1953 Mar;7(1):68-72.
  5. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer 1957 Jun;11(2):161-169.
  6. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971 Apr;68(4):820-823.
  7. A new classification of potentially malignant disorders of the oral cavity. Oral Oncol 2011 Sep;47(9):920-921.
  8. Oral potentially malignant disorders: a proposal for terminology and definition with review of literature. J Oral Maxillofac Pathol 2014 Sep;18(Suppl 1):S77-S80.
  9. Oral (mucosal) potentially malignant disorders. Oral Oncol 2012 Oct;48(10):e35-e36.
  10. Oral squamous cell carcinoma prone disorders/individuals. Oral Oncol 2015 Jan;51(1):e4.
  11. Oral potentially malignant disorders: precising the definition. Oral Oncol 2012 Sep;48(9):759-760.
  12. Sur un syndrome progressif cormprenant des télangiectasies capillaires cutanées et conjonctivales symétriques, à disposition naevoïde et des troubles cérébelleux. Confinia Neurol 1941;4:32-42.
  13. Ataxia-telangiectasia: an overview. In: Gatti RA, Swift M, editors. Ataxia-telangiectasia: genetics, neuropathy, and immunology of a degenerative disease of childhood. Vol. 9. Kroc Foundation Series. New York (NY): Alan R. Liss; 1985. p. 1-63.
  14. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle. DNA Repair (Amst) 2008 Jul;7(7):1028-1038.
  15. Ataxia-telangiectasia: an evolving phenotype. DNA Repair (Amst) 2004 Aug-Sep;3(8-9):1187-1196.
  16. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995 Jul 23;268(5218):1749-1753.
  17. Ataxia telangiectasia. Semin Pediatr Neurol 1998 Dec;5(4):287-294.
  18. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology 2000 Apr;54(7):1505-1509.
  19. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics 1998 Jul;102(1 Pt 1):98-100.
  20. Cutaneous granulomatous lesions in patients with ataxia-telangiectasia. J Pediatr 1991 Dec;119(6):917-922.
  21. Immunodeficiency and infections in ataxiatelangiectasia. J Pediatr 2004 Apr;144(4):505-511.
  22. Lymphoid tumors and breast cancer in ataxia telangiectasia: substantial protective effect of residual ATM kinase activity against childhood tumors. British J Cancer 2011 Aug 9;105(4):586-591.
  23. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 2005 Jun 1;97(11):813-822.
  24. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006 Aug;38(8):873-875.
  25. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 1988 Dec 8;336(6199):577-580.
  26. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 2001;83:209-254.
  27. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005 Jan 1;33(Database issue):D514-D517.
  28. Andrews’ diseases of the skin: clinical dermatology. 10th ed. Philadelphia (PA): Saunders;2005. p. 575.
  29. Regulation and localization of the bloom syndrome protein in response to DNA damage. J Cell Biol 2001 Apr 16;153(2):367-380.
  30. Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs: probably a syndrome entity. AMA Am J Dis Child 1954 Dec;88(6):754-758.
  31. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population. Mol Genet Metab 1998 Aug;64(4):286-290.
  32. Bloom syndrome: a Mendelian prototype of somatic mutational disease. Medicine 1993 Nov;72(6):393-406.
  33. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol 2004 Oct;24(19):8437-8446.
  34. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 1995 Nov 17;83(4):655-666.
  35. Bloom's syndrome. Dermatol Clin 1995 Jan;13(1):7-18.
  36. Available from:
  37. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med 2010 May 20;362(20):1909-1919.
  38. Ethel Moustacchi. 2003 Oct.
  39. A new trisomic syndrome. Lancet 1960 Apr 9;1(7128):787-790.
  40. The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. Ann Rev Biophys 2014;43:257-278.
  41. Numerical chromosomal changes and risk of development of myelodysplastic syndrome-acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet 2010 Dec;203(2):180-186.
  42. Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells. Blood 2005 Jul 1;106(1):75-85.
  43. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the EBMT experience. Blood 2013 Dec 19;122(26):4279-4286.
  44. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989 Feb;73(2):391-396.
  45. FANCM connects the genome instability disorders Bloom's syndrome and Fanconi anemia. Mol Cell 2009 Dec;36(6):943-953.
  46. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 1969 Oct;71(4):747-752.
  47. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990 Nov 30;250(4985):1233-1238.
  48. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 2002 Apr;39(4):225-242.
  49. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet 2004 Aug 15;129(1):74-84.
  50. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994 Mar 1;54(5):1298-1304.
  51. Germline mutations in the TP53 gene. Cancer Surv 1995;25:101-124.
  52. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003 Mar;21(3):313-320.
  53. Andrews’ diseases of the skin: clinical dermatology. 10th ed. Philadelphia (PA): Saunders; 2005.
  54. Genetic instabilities in human cancers. Nature 1998 Dec;396(6712):643-649.
  55. Photosensitivity, corneal scarring and developmental delay: Xeroderma Pigmentosum in a tropical country. Cases J 2008 Oct 20;1(1):254.
  56. DNA repair and mutagenesis. Washington (DC): ASM Press; 2006. p. 1118.
  57. DNA damage, DNA repair, and alcohol toxicity-a review. Alcohol Clin Exp Res 1997 Sep;21(6):1073-1082.
  58. Concepts in biology. 14th ed. New York (NY): McGraw-Hill; 2007. p. 173.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.